173 related articles for article (PubMed ID: 6940442)
1. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
3. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.
Marks SM; Baltimore D; McCaffrey R
N Engl J Med; 1978 Apr; 298(15):812-4. PubMed ID: 273142
[TBL] [Abstract][Full Text] [Related]
4. Leukemia cutis in blastic transformation of chronic myelocytic leukemia: TdT positive blasts and response to vincristine and prednisone.
Ansell JE; Bhawan J; Pechet L
J Cutan Pathol; 1980 Oct; 7(5):302-9. PubMed ID: 6933170
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor level, terminal deoxynucleotidyl transferase activity and initial responsiveness to prednisone and vincristine in leukemia.
Ho AD; Stojakowits S; Pralle H; Dörner M; Hunstein W
Klin Wochenschr; 1983 May; 61(9):455-9. PubMed ID: 6575218
[TBL] [Abstract][Full Text] [Related]
6. Terminal deoxynucleotidyl transferase activity in blastic phase of chronic myelogenous leukemia.
Srivastava BI; Khan SA; Minowada J; Gomez GA; Rakowski I
Cancer Res; 1977 Oct; 37(10):3612-8. PubMed ID: 269010
[No Abstract] [Full Text] [Related]
7. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
Paciucci PA; Keaveney C; Cuttner J; Holland JF
Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase activities and glucocorticoid receptors in leukaemia.
Sasaki R; Takaku F; Aoki T; Bollum FJ; Saito T; Dan S
Br J Cancer; 1981 Jul; 44(1):63-7. PubMed ID: 7259961
[TBL] [Abstract][Full Text] [Related]
9. Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis.
Ross DD; Wiernik PH; Sarin PS; Whang-Peng J
Cancer; 1979 Nov; 44(5):1566-70. PubMed ID: 291471
[TBL] [Abstract][Full Text] [Related]
10. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
11. Terminal-deoxynucleotidyl-transferase immunofluorescence on bone marrow smears: serial studies on 28 patients.
Miller WM; Stass SA; Schumacher HR; Bollum FJ
Am J Hematol; 1981; 10(1):1-7. PubMed ID: 7020412
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics.
Paietta E; Schwarzmeier JD
Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of the terminal deoxynucleotidyl transferase (TdT) activity in treating the blastic phase (bp) of chronic granulocytic leukaemia (CGL).
Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M; Duraj M; Jarczok K; Hołowiecka B; Suhs M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):864-71. PubMed ID: 2419215
[TBL] [Abstract][Full Text] [Related]
16. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
Schwarzmeier JD; Haas O; Paietta E; Fischer P
Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
[TBL] [Abstract][Full Text] [Related]
17. Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cells.
Campagnari F; Bombardieri E; de Braud F; Baldini L; Maiolo AT
Int J Biol Markers; 1987; 2(1):31-42. PubMed ID: 3323341
[TBL] [Abstract][Full Text] [Related]
18. [A case of Ph1-positive chronic myeloid leukemia blast crisis with a high level of terminal deoxynucleotidyl transferase responded to vincristine and prednisolone therapy (author's transl)].
Nagai K; Nesumi N; Higashida M; Nagata I; Ueshima Y; Sawada H; Uchino H
Rinsho Ketsueki; 1979 Sep; 20(9):1154-61. PubMed ID: 292803
[No Abstract] [Full Text] [Related]
19. Terminal deoxynucleotidyl transferase-positive lymphadenopathy in acute-phase chronic granulocytic leukemia.
Chillar RK; Wolf JL; Bearman RM; Teplitz RL
Am J Clin Pathol; 1981 Mar; 75(3):403-6. PubMed ID: 6938125
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Benedetto P; Mertelsmann R; Szatrowski TH; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
J Clin Oncol; 1986 Apr; 4(4):489-95. PubMed ID: 3958762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
